Effectiveness Of Respiratory Syncytial Virus Immunoprophylaxis On Bronchiolitis Hospitalization Among High-Risk Infants

被引：0
|
作者：
Wu, P. [1 ]
Escobar, G. J. [2 ]
Gebretsadik, T. [3 ]
Carroll, K. [1 ]
Li, S. [2 ]
Walsh, E. [2 ]
Mitchel, E. [1 ]
Sloan, C. [4 ]
Dupont, W. [3 ]
Yu, C. [3 ]
Hartert, T. V. [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Kaiser Permanente Northern Calif, Oakland, CA USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Brigham Young Univ, Provo, UT 84602 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3029
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of palivizumab for respiratory syncytial virus infection in high-risk infants in Japan
    Ikeda, S.
    Kobayashi, M.
    VALUE IN HEALTH, 2007, 10 (03) : A170 - A170
  • [22] Nirsevimab effectiveness against hospital admission for respiratory syncytial virus bronchiolitis in infants
    Rodriguez-Fernandez, Rosa
    Gonzalez-Martinez, Felipe
    Velazquez, Ines Ojeda
    Diaz, Marta Rodriguez
    Bucciol, Maria Victoria Capozzi
    Gonzalez-Sanchez, Maria Isabel
    Perez-Moreno, Jimena
    del Castillo, Blanca Toledo
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2024, 37 (06)
  • [23] Economic evaluations of immunoprophylaxis in infants at high risk for respiratory syncytial virus - Shedding light or creating confusion?
    Klassen, TP
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2002, 156 (12): : 1180 - 1181
  • [24] Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
    Mejias, Asuncion
    Ramilo, Octavio
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (03): : 433 - 439
  • [25] Respiratory syncytial virus (RSV) immunoprophylaxis in a high-risk urban population: A comparison of delivery strategies and outcomes
    Hand, IL
    Geiss, DM
    Noble, LM
    Shotkin, AM
    PEDIATRIC RESEARCH, 2003, 53 (04) : 334A - 334A
  • [26] Healthcare resource utilization and costs in the 12 months following hospitalization for respiratory syncytial virus or unspecified bronchiolitis among infants
    Ledbetter, Joel
    Brannman, Lance
    Wade, Sally W.
    Gonzales, Tara
    Kong, Amanda M.
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (02) : 139 - 147
  • [27] Immunoprophylaxis for respiratory syncytial virus
    Sánchez, PJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (05) : 473 - 478
  • [28] DETECTION OF RESPIRATORY SYNCYTIAL VIRUS IN ACUTE BRONCHIOLITIS IN INFANTS
    CUBIE, HA
    INGLIS, JM
    LESLIE, EE
    EDMUNDS, AT
    TOTAPALLY, B
    JOURNAL OF MEDICAL VIROLOGY, 1992, 38 (04) : 283 - 287
  • [29] Respiratory Syncytial Virus Bronchiolitis in Infancy: The Acute Hospitalization Cost
    Bozzola, Elena
    Ciarlitto, Claudia
    Guolo, Stefano
    Brusco, Carla
    Cerone, Gennaro
    Antilici, Livia
    Schettini, Livia
    Piscitelli, Anna Lucia
    Chiara Vittucci, Anna
    Cutrera, Renato
    Raponi, Massimiliano
    Villani, Alberto
    FRONTIERS IN PEDIATRICS, 2021, 8
  • [30] Hospitalization for Respiratory Syncytial Virus Bronchiolitis and Disease Severity in Twins
    Dotan, Miri
    Ashkenazi-Hoffnung, Liat
    Samra, Zmira
    Livni, Gilat
    Yarden-Bilavsky, Havatzelet
    Amir, Jacob
    Bilavsky, Efraim
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2013, 15 (11): : 701 - 704
12345